Technology investors expect a clear, concise business plan showing that you're aware of competitive, legal, regulatory, and manufacturing issues. We can assist you in preparing all the materials you need to make a positive impression: a thorough business plan, an accurate financial forecast, and a compelling investor presentation. Our services include developing timelines and cost estimates to meet financial constraints and milestone goals; due diligence; and in-licensing evaluation.
PharmaNet professionals available for consultation on this topic include:
Executive Director, PharmaNet Consulting
Joyce Lea Frey-Vasconcells, PhD
Executive Director, PharmaNet Consulting
Senior Vice President, Regulatory Affairs Worldwide
Executive Vice President, Biostatistics
Director, Drug Development, Scientific and Regulatory Affairs, Anapharm
Project Manager, Drug Development, Scientific and Regulatory Affairs, Anapharm
Executive Director, Strategic Partnering Services
Executive Director, PharmaNet Consulting
504 Carnegie Center, Princeton, NJ 08540